Susquehanna International Group’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $135K | Buy |
+46,600
| New | +$99.4K | ﹤0.01% | 12117 |
|
|
2025
Q4 | – | Sell |
-35,700
| Closed | -$60K | – | 13099 |
|
|
2025
Q3 | $60K | Buy |
35,700
+15,300
| +75% | +$24.8K | ﹤0.01% | 11799 |
|
|
2025
Q2 | $24.7K | Buy |
20,400
+8,500
| +71% | +$12.3K | ﹤0.01% | 12287 |
|
|
2025
Q1 | $15.1K | Buy |
+11,900
| New | +$31.1K | ﹤0.01% | 12176 |
|
|
2024
Q4 | – | Sell |
-41,300
| Closed | -$136K | – | 12824 |
|
|
2024
Q3 | $136K | Buy |
41,300
+1,500
| +4% | +$5.84K | ﹤0.01% | 10830 |
|
|
2024
Q2 | $169K | Sell |
39,800
-58,600
| -60% | -$571K | ﹤0.01% | 10571 |
|
|
2024
Q1 | $1.45M | Buy |
98,400
+79,300
| +415% | +$1.2M | ﹤0.01% | 6087 |
|
|
2023
Q4 | $184K | Buy |
19,100
+2,600
| +16% | +$18K | ﹤0.01% | 10767 |
|
|
2023
Q3 | $76.9K | Buy |
+16,500
| New | +$82.1K | ﹤0.01% | 11090 |
|
|
2022
Q4 | – | Sell |
-10,600
| Closed | -$37K | – | 13176 |
|
|
2022
Q3 | $37K | Buy |
+10,600
| New | +$40.5K | ﹤0.01% | 12367 |
|
|
2022
Q1 | – | Sell |
-17,400
| Closed | -$279K | – | 13589 |
|
|
2021
Q4 | $279K | Buy |
17,400
+7,500
| +76% | +$141K | ﹤0.01% | 10660 |
|
|
2021
Q3 | $207K | Sell |
9,900
-33,700
| -77% | -$812K | ﹤0.01% | 11416 |
|
|
2021
Q2 | $1.17M | Sell |
43,600
-23,000
| -35% | -$674K | ﹤0.01% | 7320 |
|
|
2021
Q1 | $2.12M | Buy |
+66,600
| New | +$1.62M | ﹤0.01% | 5791 |
|
|
2020
Q4 | – | Sell |
-50,200
| Closed | -$1.26M | – | 11449 |
|
|
2020
Q3 | $1.26M | Sell |
50,200
-65,800
| -57% | -$1.8M | ﹤0.01% | 5545 |
|
|
2020
Q2 | $3.24M | Buy |
+116,000
| New | +$2.01M | ﹤0.01% | 3671 |
|
|
2020
Q1 | – | Sell |
-48,700
| Closed | -$530K | – | 10634 |
|
|
2019
Q4 | $530K | Sell |
48,700
-7,600
| -13% | -$75.2K | ﹤0.01% | 6875 |
|
|
2019
Q3 | $718K | Sell |
56,300
-40,300
| -42% | -$580K | ﹤0.01% | 6462 |
|
|
2019
Q2 | $1.64M | Buy |
96,600
+23,000
| +31% | +$395K | ﹤0.01% | 4575 |
|
|
2019
Q1 | $1.32M | Buy |
+73,600
| New | +$1.27M | ﹤0.01% | 4465 |
|
|
2018
Q1 | – | Sell |
-61,500
| Closed | -$1.17M | – | 9830 |
|
|
2017
Q4 | $1.17M | Buy |
61,500
+21,700
| +55% | +$405K | ﹤0.01% | 4924 |
|
|
2017
Q3 | $736K | Buy |
39,800
+17,200
| +76% | +$298K | ﹤0.01% | 5839 |
|
|
2017
Q2 | $396K | Buy |
22,600
+300
| +1% | +$5.72K | ﹤0.01% | 7071 |
|
|
2017
Q1 | $415K | Sell |
22,300
-3,400
| -13% | -$65.6K | ﹤0.01% | 6824 |
|
|
2016
Q4 | $525K | Sell |
25,700
-15,900
| -38% | -$400K | ﹤0.01% | 6872 |
|
|
2016
Q3 | $1.24M | Buy |
41,600
+15,600
| +60% | +$464K | ﹤0.01% | 4391 |
|
|
2016
Q2 | $702K | Buy |
+26,000
| New | +$586K | ﹤0.01% | 5525 |
|
|
2016
Q1 | – | Sell |
-14,100
| Closed | -$437K | – | 9416 |
|
|
2015
Q4 | $437K | Buy |
+14,100
| New | +$428K | ﹤0.01% | 7028 |
|
Other funds holding MGNX
AC
VCM
RCM
WA
Susquehanna International Group's MGNX Position: Q1 2026 in Review
Susquehanna International Group increased its MacroGenics (MGNX) stake by 560% in Q1 2026, buying an estimated $818K and bringing the position to 452,227 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #7218.
Susquehanna International Group first reported a position in MGNX in Q4 2014 and has held it in 37 quarters since. The position peaked at $7.83M in Q1 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.
- Susquehanna International Group held 452,227 shares of MacroGenics worth $1.31M as of Q1 2026.
- Susquehanna International Group bought 383,686 MacroGenics shares in Q1 2026, an estimated $818K.
- MacroGenics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7218 holding.
- Susquehanna International Group first reported a position in MacroGenics in Q4 2014 and has held it in 37 quarters since.
- Susquehanna International Group's MacroGenics position peaked at $7.83M in Q1 2024.
- 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.